Cite
HARVARD Citation
Xie, L. et al. (2017). Sphingolipidomic study of davidiin-treated HepG2 human hepatocellular carcinoma cells using UHPLC-MS. RSC advances. 7 (87), pp. 55249-55256. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, L. et al. (2017). Sphingolipidomic study of davidiin-treated HepG2 human hepatocellular carcinoma cells using UHPLC-MS. RSC advances. 7 (87), pp. 55249-55256. [Online].